Innovative Design Alcove (IDEAL) Program

This service is provided by the BERD Resource's Trial Design Innovation Core

Overview

The BERD Trial Design Innovation Core, in collaboration with the Trial Innovation Network (TIN), is launching a new pilot program for investigators looking to incorporate innovative clinical trial designs into a future grant proposal. The program will select promising submissions and facilitate the development of their proposal’s clinical trial objectives & endpoints, study design, statistical considerations, and potentially other key areas such as budgeting, grantsmanship and regulatory compliance.

IDEAL Faculty Expertise: Bayesian adaptive designs; N of 1; Sequential, Multiple Assignment, Randomized Trial (SMART) design

Scope of the program

Successful applicants can expect:

• Twice-monthly meetings with course faculty to ensure structure and timeliness in completing the tasks required to successfully submit a grant application by June 2024
• Guidance on innovative trial design by Biostatistics faculty at each meeting
• Access to other Irving Institute services and programs
• Expert review on a working draft of your grant proposal application

2024 IDEAL Session Offerings & Tentative Schedule

• January – Introductory Session & Aims
• February – Innovation
• March – Approach (includes trial design)
• April – Budgeting & Bio-sketch
• May – Present grant proposal to IDEAL Course Faculty

Eligibility

IDEAL welcomes all applicants and clinical trial ideas, but applications will be prioritized by:

• Departments or investigators with limited resources to develop a clinical trial
• Domains of interest:
  • AI/ML
  • Health equity
  • Learning health systems
  • Precision medicine
  • Rare disease

Deadline

Applications are now closed for this award cycle. Expected to open again in Spring 2024.